Asia-pacific Biopsy Devices Market Forecast 2024-2032
KEY FINDINGS
The Asia-Pacific biopsy devices market is anticipated to progress at a CAGR of 8.38% over the forecast period of 2024-2032. The market growth is fostered by several factors, including the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.
MARKET INSIGHTS
The Asia-Pacific biopsy devices market is going through substantive growth, promoted by a surge in healthcare expenditure across the region. As countries in the Asia-Pacific increase their focus on healthcare infrastructure and services, the demand for biopsy devices has witnessed a significant upswing. This surge in healthcare spending highlights the region's commitment to enhancing medical facilities and diagnostics.
In addition to the focus on personalized medicine, the expanding applications of biopsy devices across various medical specialties contribute significantly to the market's growth. Biopsy procedures are no longer confined to a specific medical field but are increasingly utilized in diverse areas such as oncology, cardiology, and gastroenterology.
This broadening scope of applications positions biopsy devices as versatile tools, developing their adoption across multiple medical disciplines. The increasing recognition of biopsy devices as valuable assets in various specialties is driving market expansion and influencing the development of innovative, specialized biopsy solutions. As a result, these factors are set to promote the market’s growth in Asia-Pacific during the forecast period.
COMPETITIVE INSIGHTS
Some of the major companies in the Asia-Pacific biopsy devices market include Hologic Inc, Cook Medical, Inrad Inc, DTR Medical, Cardinal Health, Argon Medical Devices, Boston Scientific, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Methodology
- 1.3. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 2.3. Scope Of Study
- 2.4. Crisis Scenario Analysis
- 2.4.1. Impact Of Covid-19 On Biopsy Devices Market
- 2.5. Major Market Findings
- 2.5.1. Growing Emphasis On Personalized Medicine
- 2.5.2. Expanding Applications Across Medical Specialities
- 2.5.3. Development Of Cost-effective Biopsy Solutions
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Prevalence Of Cancer
- 3.1.2. Increasing Demand For Minimally Invasive Surgeries
- 3.1.3. Surge In The Number Of Hospitals And Diagnostic Centers
- 3.2. Key Restraints
- 3.2.1. High Risk Of Infection For Patients
- 3.2.2. High Cost Of Biopsy Procedures
- 3.2.3. Lack Of Skilled Professionals
- 4. Key Analytics
- 4.1. Key Market Trends
- 4.1.1. Surge In The Healthcare Expenditure
- 4.1.2. Shift Towards Preventive Healthcare
- 4.1.3. Advancements In Biopsy Technology
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Buyers Power
- 4.2.2. Suppliers Power
- 4.2.3. Substitutions
- 4.2.4. New Entrants
- 4.2.5. Industry Rivalry
- 4.3. Growth Prospect Mapping
- 4.4. Value Chain Analysis
- 4.4.1. Raw Materials
- 4.4.2. Manufacturers
- 4.4.3. Distribution
- 4.4.4. End-users
- 5. Market By Product
- 5.1. Needle- Based Biopsy Guns
- 5.1.1. Vacuum-assisted Biopsy (Vab) Devices
- 5.1.2. Fine Needle Aspiration Biopsy (Fnab) Devices
- 5.1.3. Core Needle Biopsy (Cnb) Devices
- 5.2. Biopsy Guidance Systems
- 5.3. Biopsy Needles
- 5.4. Biopsy Forceps
- 5.5. Other Products
- 6. Market By Application
- 6.1. Oncology
- 6.2. Gastroenterology
- 6.3. Pulmonology
- 6.4. Dermatology
- 6.5. Other Applications
- 7. Market By End Use
- 7.1. Hospitals
- 7.2. Ambulatory Surgical Centers
- 7.3. Diagnostic Centers
- 8. Geographical Analysis
- 8.1. Asia-pacific
- 8.1.1. Market Size & Estimates
- 8.1.2. Asia-pacific Biopsy Devices Market Drivers
- 8.1.3. Asia-pacific Biopsy Devices Market Challenges
- 8.1.4. Key Players In Asia-pacific Biopsy Devices Market
- 8.1.5. Country Analysis
- 8.1.5.1. China
- 8.1.5.2. Japan
- 8.1.5.3. India
- 8.1.5.4. South Korea
- 8.1.5.5. Taiwan
- 8.1.5.6. Singapore
- 8.1.5.7. Australia & New Zealand
- 8.1.5.8. Rest Of Asia-pacific
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.1.4. Business Expansions & Divestitures
- 9.2. Company Profiles
- 9.2.1. Cardinal Health
- 9.2.2. Hologic Inc
- 9.2.3. Danaher Corporation
- 9.2.4. Conmed Corporation
- 9.2.5. Cook Medical
- 9.2.6. Dtr Medical
- 9.2.7. Inrad Inc
- 9.2.8. Boston Scientific
- 9.2.9. Medtronic Plc
- 9.2.10. Becton Dickinson And Company
- 9.2.11. Mammotome
- 9.2.12. Argon Medical Devices
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook